• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 12, 2002

View Archived Issues

Cyclis licenses broad technology to expand ACT platform

Read More

Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy

Read More

APT-3111 awarded E.U. orphan drug status for paroxysmal nocturnal hemoglobinuria

Read More

New modulators of adenosine receptors identified at Bayer

Read More

Japanese patent covers novel alpha2-adrenoceptor antagonists designed by Fuso scientists

Read More

Several related series of guanylate cyclase activators described by Bayer

Read More

New antitumor hydroxamates prepared and tested at Ono

Read More

Ono scientists design novel chemokine antagonists for asthma, arthritis, etc.

Read More

Tropane analogue RTI-336 as a potential therapeutic for cocaine abuse

Read More

New mu/delta opioid receptor agonist under study for the management of GI motility disorders

Read More

Beneficial effects for NCX-1000 in animal model of cholangitis

Read More

Major active component of TJ-135 determined using hepatic stellate cells

Read More

Data supporting ongoing clinical development of ACH-126443 for HBV presented at meetings

Read More

Effect of emerging precore stop codon mutation on anti-HBV activity of LY-582563/MCC-478

Read More

Antitumor activity of TRAIL-R1 MAb demonstrated in vitro and in vivo

Read More

Preclinical data reported for Ono-2506 at Neuroscience 2002

Read More

OraQuick rapid HIV-1 test approved

Read More

Inflazyme announces phase Ia and Ib results with IPL-512602

Read More

ENMD-0995 receives orphan drug designation

Read More

Aphton initiates clinical trials with G17DT for GERD in Europe

Read More

Pay now or pay later: new report sheds light on the economic impact of osteoporosis in the workplace

Read More

Inspire announces phase II results with INS-37217

Read More

Top-line results of phase III study of alvimopan in opioid bowel dysfunction

Read More

Evidence supporting the use of neurokinin receptor antagonists in depression

Read More

FDA designates Orathecin as a fast track drug

Read More

HuMax-CD4 to be tested in cancer patients

Read More

Cetirizine approved for pediatric use

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe